Stealthy Adesto lands $14M for fabless semiconductors
Adesto Technologies, a fabless semiconductor company that’s so secretive that there’s no content on its web site, has raised $14 million in equity and warrants, according to a regulatory filing. Based in Sunnyvale, Calif., the three-year-old company has a pretty healthy funding history. It raised… Continue Reading
Integral Development raises $11M for electronic foreign exchange trades
Integral Development, provider of a software platform that connects global financial institutions for electronic foreign exchange trading, just raised $11 million in a round of capital provided in part by Adams Street Partners. The system allows individual investors to make their own trusted trades or… Continue Reading
Revascular adds $3M to clear arteries
Revascular Therapeutics, maker of a device that helps doctors clear blockages in major arteries, has tacked on $3 million to a second round of funding, bringing its total to $11 million, reports VentureWire. The Sunnyvale, Calif., company hopes to add $1 million more to fully… Continue Reading
Neuraltus scores $17M to treat degenerative brain disease
Neuraltus Pharmaceuticals, developer of drugs used to treat degenerative neurological diseases, brought in $17 million in a first round of funding from Latterell Venture Partners, VantagePoint Venture Partners and Adams Street Partners. The Menlo Park, Calif.-based company says it’s currently working on therapies for conditions… Continue Reading
Jaspersoft raises $12.5M for open source business intelligence
Jaspersoft, a provider of open-source business intelligence software, has raised $12.5 million in new funding. The round was led by Adams Street Partners, with participation from leading open-source company Red Hat and Jaspersoft’s previous investors Scale Venture Partners, SAP Ventures, DCM, Morgenthaler Ventures, and Partech… Continue Reading
OncoMed nabs $93M for stem cell programs
OncoMed Pharmaceuticals, a company working to fight cancer using stem cells, added a $93 million tranche to a second round of funding that now totals $154 million. The money will be used to push its lead antibody candidate through phase-two clinical trials.
The Redwood City, Calif…. Continue Reading
Proteus snaps up $30M to take on heart failure
Proteus Biomedical Inc., a company developing microscopic electromechanical devices capable of one day treating or preventing congestive heart failure, brought in more than $30 million in its first call for fourth round financing. It’s original goal was $28.6 million, but CEO Andrew Thompson says the… Continue Reading
Sportgenic raises $10M for sports ad network
Sportgenic, a company that claims to provide high-value market reach to sports advertisers and marketers, has raised $10 million in a second round of funding.
The company targets specific groups of sports enthusiasts based on their predilections, from country club members to outdoorsmen and team athletes…. Continue Reading
Visible World, a targeted cable advertiser, raises $25M
Targeted advertising, based on geographic location, age, gender and other factors, is a pretty common concept by now. Visible World wants to bring it to cable television, with an added twist — editing of specific commercial spots to appeal more to individuals.
Say a large company… Continue Reading
Paylocity gets venture payroll of $10M
Paylocity, a startup that provides payroll and human services software, has raised $10 million at a valuation of more than $60 million, according to VentureWire.
The Arlington Heights, Ill.-based company has been boostrapped since it was founded in 1997, and it has 180 employees and almost… Continue Reading
Life-science briefing: Tuesday, March 18, 2008
TODAY’S HEADLINES:
Luminous Medical raises $24M for automated glucose monitoring (release)
Alimera Sciences gets $30M for eye-disease drug (release)
Vaccine maker LigoCyte draws $28M (release)
Heartbeat tracker CardioNet trims IPO, aims for listing today (IPOhome)
Axial Biotech takes in $6M for spinal diagnostics (release)
Insulin bioengineer enGene receives $6.4M (release)
GlucoLight raises… Continue Reading
Roundup: Amazon S3, VentureBeat go down, Montalvo’s mobile chip and more
1. Amazon S3, VentureBeat go down
2. Montalvo Systems vs. Intel, with chip for handheld devices
3. Fox Interactive to introduce “music Hulu for MySpace”
4. Yahoo’s board moving against Yang
5. Google searchers are wealthier, buy more online
6. Xobni hires Jeff Bonforte away from Yahoo, to be its… Continue Reading
Microsoft gobbles up Danger, maker of the Sidekick mobile software
Microsoft Corp has agreed to acquire Danger, a Silicon Valley company that makes the software for the Sidekick and other mobile devices, for an undisclosed amount.
Danger has worked away for ten years on its device software, and recently filed for an IPO, which we termed… Continue Reading
Ticketmaster to buy ticket reseller TicketsNow for $265M
Ticketmaster, the large ticket seller, said it would buy entertainment event ticket reseller TicketsNow for $265 million.
Ticketmaster has long been the monster of ticket sales, but it has been greedy, charging high fees for its service, and now it is facing increasing competition. Even this… Continue Reading
Life sciences briefing: Wednesday, Nov. 28, 2007
Featured companies: American Aerogel, Clinicient, Frazier Healthcare Ventures, Genome Diagnostics, RadPharm, RainDance Technologies, Vivacta
UPDATED: Expanded items on Vitae, RadPharm, Vivacta and Genome Diagnostics. Intelligent Bio-Systems is now covered in a standalone item here.
Vitae Pharma takes in $15M for blood pressure, diabetes drugs — Vitae Pharmaceuticals, a Fort… Continue Reading
Life sciences briefing: Monday, Nov. 12, 2007
(UPDATED: See below.)
Featured companies: Anaptys Biosciences, Arterial Remodeling Technologies, Cambria Biosciences, CaseNet, ChemoCentryx, Ensemble Discovery, MediQuest, Piedmont Pharmaceuticals, Raven Biotechnologies, Sensys Medical, Verus Pharmaceuticals, Xanodyne Pharmaceuticals
UPDATED: Expanded items on Anaptys, Arterial Remodeling, Raven Biotech, Sensys and MediQuest. Moved ChemoCentryx and Xanodyne to a separate item.
Antibody-drug maker Raven Biotech… Continue Reading
Life sciences briefing: Wednesday, Oct. 17, 2007
Featured companies: Algorithme Pharma, Bacchus Vascular, Botaneco, Cubist Pharmaceuticals, Ikonisys, Healthcare Management Systems, Illumigen Biosciences, Kilmer Capital Partners, Medical Specialties Distributors, Metastatix, Microphage, Orthosoft, Thomas McNerney & Partners, TranS1, TriReme Medical, Wren Medical, Zimmer
UPDATE: Expanded TriReme Medical, Ikonisys and TranS1 items.
UPDATE REDUX: Added MicroPhage item.
Stent-maker TriReme… Continue Reading
Life sciences briefing: Wednesday, Sept. 26, 2007
Featured companies: Ablynx, Cardiosolutions, Carigent Thereapeutics, Elusys, Genome Corp., GlobeImmune, Novazone, Targanta Therapeutics, Waterfront Media
UPDATED at 5:45am on 9/27/07
GlobeImmune raises $41M for immune-system therapies — GlobeImmune, a Louisville, Colo., biotech focused on new forms of immunotherapy to treat viral infections and cancer, raised $41.2 million in… Continue Reading
WhiteFence, a residential home services shopping site, raises $14M
WhiteFence, a company in Houston, Texa that offers a comparison shopping site for people looking for residential home services (Internet connections, home phone accounts, electricity, natural gas, etc), said it has raised $14 million in a second round of funding.
Adams Street Partners led the round,… Continue Reading
Jazz Pharmaceuticals files for gutsy $172M IPO
Jazz Pharmaceuticals, a Palo Alto, Calif. company that seeks to license drugs from other companies, buy other drug companies and develop its own drugs, all in the area neurology and psychiatry, has filed for a $172.5 million IPO.
Here is its filing. It is four years… Continue Reading